Allergy & Immunology

Benralizumab has shown efficacy in reducing asthma exacerbations and controlling symptoms in severe eosinophilic asthma.

Parental anxiety improved initially, while adults reported better problem-focused coping and reduced depression over 3 months.

The results revealed a clear impact as vaccination rates rose by 1.8% among heart attack survivors and by 1.3% in adults without a history of heart attack.

Findings from the VOYAGE and EXCURSION studies confirm the efficacy of dupilumab in children aged 6–11 years with moderate-to-severe type 2 asthma.

In a small Swiss study, patients with adult-onset egg white allergy exhibited moderate to severe restrictions in daily life.

Dysbiosis, or microbial imbalance, can predispose individuals to allergies, while a balanced gut microbiome fosters immune tolerance.

The trial highlighted that the Zagreb regimen led to fewer doses and a shorter vaccination period, improving compliance and cost-effectiveness.

The trial found increased beneficial gut bacteria such as Lactobacillus and Bifidobacterium, alongside reduced pro-inflammatory species.